BONUS CAP-ZERTIFIKAT - ROCHE GS Stock

Certificat

DE000VM4A0M6

Delayed Deutsche Boerse AG 04:23:23 2024-06-10 am EDT
285.9 EUR -0.06% Intraday chart for BONUS CAP-ZERTIFIKAT - ROCHE GS
Current month+1.64%
1 month+2.89%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-10 285.9 -0.06%
24-06-07 286.1 +0.33%
24-06-06 285.2 +0.11%
24-06-05 284.8 -0.26%
24-06-04 285.6 +0.85%

Delayed Quote Deutsche Boerse AG

Last update June 10, 2024 at 04:23 am EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WKN VM4A0M
ISINDE000VM4A0M6
Date issued 2023-10-23
Strike 280 CHF
Maturity 2024-09-20 (103 Days)
Parity 1 : 1
Emission price 276.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 291.2
Lowest since issue 266.1
Spread 0.06
Spread %0.02%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
242.6 CHF
Average target price
277.5 CHF
Spread / Average Target
+14.40%
Consensus